Nohla Therapeutics Inc
Total Awards:
1
Award Value:
$4,310,000
Institution type:
For profit
Short Name:
Nohla Therapeutics
Awards to the Institution
| Program | Investigator | Award Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Colleen Delaney | A Phase 2 Open-Label, Multi-Center, Randomized, Controlled, Optimal Dose-Finding Study of DCC-UCB in Adults Receiving High Dose Chemotherapy for AML | $4,310,000 |
Total: $4,310,000.00 |
